• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Ukraine invasion

Europeans are so scared of a nuclear attack they’re panic buying iodine tablets

Christiaan Hetzner
By
Christiaan Hetzner
Christiaan Hetzner
Senior Reporter
Down Arrow Button Icon
Christiaan Hetzner
By
Christiaan Hetzner
Christiaan Hetzner
Senior Reporter
Down Arrow Button Icon
March 8, 2022, 1:04 PM ET

Amid a nightmare scenario of nuclear fallout, some Europeans fearful of an escalation in Russia’s war on Ukraine have taken to stocking up on iodine tablets. 

The tablets help mitigate the threat of long-term thyroid cancer, the likes of which were seen after the Chernobyl meltdown, particularly in high-risk groups like infants and children.

In Belgium, nearly 30,000 residents went to pharmacies for free pills following Russian President Vladimir Putin’s announcement to put its nuclear deterrent forces on high alert and recent fighting at nuclear power plants in Ukraine, according to the Brussels Times.

Meanwhile, Bloomberg reported that there has been a 100-fold increase in demand for tablets in Finland ever since Russia invaded Ukraine, with pharmacies out of stock across the country. 

https://twitter.com/maryheimann/status/1499770213629370374?s=20u0026t=j2RfR8by7WBWmBBmtsRZNg

What in theory may sound sensible to have on hand can prove hazardous in real life if instructions aren’t followed carefully. Depending on one’s age, they may not even bring a net benefit.

“Taking [potassium iodide] more often than recommended does not offer more protection and can cause severe illness or death,” the U.S. Centers for Disease Control warns. 

The tablets work by saturating the thyroid with iodine for 24 hours, blocking the intake of highly radioactive iodine-131 that would otherwise be readily absorbed by the organ through contaminated air, food, or water. 

In the event of a nuclear accident or attack, the tablet’s 24-hour effect provides valuable time to seek shelter from this unstable iodine isotope. Itself a by-product of nuclear fission, iodine-131 begins to decay after just eight days.

No help against other radioactive isotopes

Furthermore, these tablets should not be taken unless there is actually a risk of imminent exposure. Ingesting the medicine preventatively without supervision can end up doing more harm than good. 

I've just been to 5 different pharmacies here in Norway and it's impossible to get iodine tablets.

All sold out and there are waiting lists.

People are preparing for nuclear war.

I don't think the war mongers out there realize the gravity of the situation.

Worse than cold war

— PeterSweden (@PeterSweden7) February 28, 2022

With many adults suffering from some form of overactive thyroid, ingesting high-dosage potassium iodide can cause harmful side effects including acute cardiovascular failure, which outweigh the increased risk of developing cancer.

Consequently, the Centers for Disease Control only recommends individuals 40 years and younger need take them in the event of a fallout.

Moreover, iodine is not a silver bullet solution for protecting oneself in a fallout. It cannot help against the threat of other common radioactive elements emitted in a blast, such as cesium-137 or strontium-90.

As a result, the chair of the Drug Commission of German Pharmacists strongly advised last week against self-administering such tablets. 

“Not only does this pose considerable health risks, it currently offers no advantage,” said Martin Schulz, citing the lack of any suspicious radioactivity emanating from Ukraine.

The commission added there was “no rational argument at present for taking high dosage iodine tablets due to the situation in Ukraine,” adding authorities had stockpiled reserves of nearly 190 million tablets should the need ever arise.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
Christiaan Hetzner
By Christiaan HetznerSenior Reporter
Instagram iconLinkedIn iconTwitter icon

Christiaan Hetzner is a former writer for Fortune, where he covered Europe’s changing business landscape.

See full bioRight Arrow Button Icon
0

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Most Popular

placeholder alt text
Law
Amazon is cutting checks to millions of customers as part of a $2.5 billion FTC settlement. Here's who qualifies and how to get paid
By Sydney LakeJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
AI layoffs are looking more and more like corporate fiction that's masking a darker reality, Oxford Economics suggests
By Nick LichtenbergJanuary 7, 2026
1 day ago
placeholder alt text
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn't pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloJanuary 6, 2026
2 days ago
placeholder alt text
Success
Diary of a CEO founder says he hired someone with 'zero' work experience because she 'thanked the security guard by name' before the interview
By Emma BurleighJanuary 8, 2026
8 hours ago
placeholder alt text
Personal Finance
Current price of silver as of Wednesday, January 7, 2026
By Joseph HostetlerJanuary 7, 2026
1 day ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.